Sinotherapeutics Inc. (SHA:688247)

Sinotherapeutics Revenue

Sinotherapeutics had revenue of 94.55M CNY in the quarter ending March 31, 2026, a decrease of -13.20%. This brings the company's revenue in the last twelve months to 432.19M, down -15.11% year-over-year. In the year 2025, Sinotherapeutics had annual revenue of 446.57M, down -12.71%.

• Revenue (ttm): 432.19M
• Revenue Growth: -15.11%
• P/S Ratio: 8.28
• Revenue / Employee: 1.39M
• Employees: 312
• Market Cap: 3.58B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	446.57M	-65.05M	-12.71%
Dec 31, 2024	511.62M	211.75M	70.61%
Dec 31, 2023	299.87M	52.31M	21.13%
Dec 31, 2022	247.56M	-67.91M	-21.53%
Dec 31, 2021	315.47M	-3.69M	-1.16%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 6, 2026

Data Sources Report a data error